UM
(Note: the search results are based on claimed items)

Browse/Search Results:  1-7 of 7 Help

Filters        
Selected(0)Clear Items/Page:    Sort:
TNFR2-expressing CD4+ Foxp3+ regulatory T cells in cancer immunology and immunotherapy Journal article
Progress in Molecular Biology and Translational Science, 2019
Authors:  Jiang He;  Ruixin Li;  Yibo Chen;  Yuanjia Hu;  Xin Chen
Favorite  |  View/Download:7/0  |  Submit date:2019/05/08
Regulatory t Cells  Immunotherapy  Cancer  Tumor Necrosis Factor Receptor Type 2  Tumor Necrosis Factor  
Modulation of Regulatory T Cell Activity by TNF Receptor Type II-Targeting Pharmacological Agents Journal article
FRONTIERS IN IMMUNOLOGY, 2018,Volume: 9
Authors:  Zou, Huimin;  Li, Ruixin;  Hu, Hao;  Hu, Yuanjia;  Chen, Xin
Favorite  |  View/Download:9/0  |  Submit date:2018/10/30
Tnf Receptor Type Ii  Regulatory t Cells  Tnf Receptor Type Ii Agonists  Tnf Receptor Type Ii Antagonists  Immunotherapy  
Blockade of TNFR2 signaling enhances the immunotherapeutic effect of CpG ODN in a mouse model of colon cancer Journal article
SCIENCE SIGNALING, 2018,Volume: 11,Issue: 511
Authors:  Nie, Yingjie;  He, Jiang;  Shirota, Hidekazu;  Trivett, Anna L.;  Yang, De;  Klinman, Dennis M.;  Oppenheim, Joost J.;  Chen, Xin
Favorite  |  View/Download:15/0  |  Submit date:2018/10/30
Expression of TNFR2 by regulatory T cells in peripheral blood is correlated with clinical pathology of lung cancer patients Journal article
Cancer Immunology, Immunotherapy, 2015,Volume: 64,Issue: 11,Page: 1475-1485
Authors:  Yan F.;  Du R.;  Wei F.;  Zhao H.;  Yu J.;  Wang C.;  Zhan Z.;  Ding T.;  Ren X.;  Chen X.;  Li H.
Favorite  |  View/Download:11/0  |  Submit date:2018/11/06
cd4+foxp3+ Regulatory t Cells  Clinical Pathology  Immunosuppression  Lung Cancer  Tumor Necrosis Factor Receptor Type Ii (Tnfr2)  
Research and development of therapeutic mAbs: An analysis based on pipeline projects Journal article
Human Vaccines and Immunotherapeutics, 2015,Volume: 11,Issue: 12,Page: 2769-2776
Authors:  Geng X.;  Kong X.;  Hu H.;  Chen J.;  Yang F.;  Liang H.;  Chen X.;  Hu Y.
Favorite  |  View/Download:7/0  |  Submit date:2018/11/06
Development Trends  Monoclonal Antibody  Patent Citation Network  Pipeline Projects  r&d  Therapeutic Application  
Regulatory T Cells and Myeloid-Derived Suppressor Cells in the Tumor Microenvironment Undergo Fas-Dependent Cell Death during IL-2/aCD40 Therapy Meeting Absctact
2012
Authors:  Jonathan M. Weiss;  Jeff J. Subleski;  Tim Back;  Xin Chen;  Stephanie K. Watkins;  Hideo Yagita;  Thomas J. Sayers;  William J. Murphy;  Robert H. Wiltrout
Favorite  |  View/Download:15/0  |  Submit date:2019/01/12
Successful immunotherapy with IL-2/anti-CD40 induces the chemokine-mediated mitigation of an immunosuppressive tumor microenvironment Journal article
Proceedings of the National Academy of Sciences of the United States of America, 2009,Volume: 106,Issue: 46,Page: 19455-19460
Authors:  Weiss J.M.;  Back T.C.;  Scarzello A.J.;  Subleski J.J.;  Hall V.L.;  Stauffer J.K.;  Chen X.;  Micic D.;  Alderson K.;  Murphy W.J.;  Wiltrout R.H.
Favorite  |  View/Download:6/0  |  Submit date:2018/11/06
Cd40  Chemokines  Tumor Immunotherapy